HOME >> MEDICINE >> NEWS
Breastfed infants show little effect when moms take anti-depressant

New Haven, Conn. -- Most breastfed infants nurse without showing meaningful effects from their mothers taking 20-40 mg of the anti-depressant fluoxetine (Prozac) daily, according to a study by Yale researchers.

Postpartum major depression affects about 10 percent of women. Prozac belongs to a class of anti-depressants known as selective serotonin reuptake inhibitors, which are the most commonly prescribed class of anti-depressants for post-partum depression.

The researchers based their findings on 11 breastfed infants before and after their mothers took Prozac for eight weeks. The infants were four weeks to 12 weeks of age during the study.

"Ten of the 11 infants experienced little or no decline in blood serotonin concentrations after exposure to fluoxetine through breast milk," said Neill Epperson, M.D., assistant professor of psychiatry and obstetrics and gynecology at Yale School of Medicine and lead author of the study in this month's Pediatrics journal.

A decline in blood serotonin levels would have suggested that the infants received enough of the drug through their mother's breast milk to affect brain serotonin function. Serotonin is a chemical in the brain that is believed to influence mood, appetite, sleep and other aspects of behavior and cognition.

Epperson said her advice to women who are thinking of breastfeeding and taking an anti-depressant is to weigh a range of factors, including the severity of the postpartum depression, their response to the anti-depressant, and their commitment to breastfeeding.

She said the infants are being evaluated for any impact of their exposure to anti-depressants on motor and cognitive development.


'"/>

Contact: Jacqueline Weaver
jacqueline.weaver@yale.edu
203-432-8555
Yale University
24-Nov-2003


Page: 1

Related medicine news :

1. UMaine study looks at infants and chronic nighttime crying
2. Hospital acquired infections present major problem for infants in developing countries
3. Cigarette smoke worsens respiratory infections in infants
4. Columbia researchers receive $3 million to combat genetic killer of infants & toddlers
5. Brain tumor with dismal prognosis in infants can be cured in older children
6. Infection in ELBW infants linked with poor neurodevelopmental, growth outcomes
7. Infection puts extremely low birth weight infants at risk for developmental delays
8. Infections in low-birth-weight infants are associated with impaired neurodevelopment and growth
9. Developmental issues among triplet infants
10. Premature infants with lung disease may continue to need replacement substance to ease breathing
11. UMHS researchers help hone use of substance to improve lung function in premature infants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... ... Mary J's Cannabis , Kingston’s premium recreational cannabis shop, achieves retail ... , The store, which operates out of a 100-year-old house in downtown Kingston, ... the company plans to expand across Canada. , “At Mary J’s Cannabis, our ...
(Date:8/5/2020)... ... August 05, 2020 , ... In its often-heroic ongoing response ... Regardless of the obstacle - shortages of tests, ventilators and ICU beds; strained ... or postponement of all nonessential services - providers across the country have found ...
(Date:8/5/2020)... Ky. (PRWEB) , ... August 05, 2020 , ... ... to help everyone gain access to essential COVID-19 information. Know NOW!, which is ... sources of COVID-19 updates and unify them in one easy-to-use mobile application. , “When ...
(Date:8/5/2020)... ... August 04, 2020 , ... Today, Power to Decide’s ... Health Programs (AMCHP) with the 2020 Innovation Station Best Practice Award. The One Key ... under what circumstances to get pregnant and have a child. One Key Question is ...
(Date:8/3/2020)... ... August 03, 2020 , ... Actuate Therapeutics, Inc. (Actuate), ... first-line advanced pancreatic cancer in a phase 2 study of 9-ING-41, as a ... 9-ING-41 is Actuate’s proprietary small molecule glycogen synthase kinase-3 beta (GSK-3ß) inhibitor ...
Breaking Medicine News(10 mins):
(Date:8/9/2020)... ... August 09, 2020 , ... Enara Health ... that Lydia C. Alexander, MD, has joined the company in the newly created ... play a vital role in expanding Enara Health’s national network of clinicians and ...
(Date:8/7/2020)... ... 2020 , ... Glewed TV, a leading video-on-demand (VOD) discovery, ... today announced a partnership with award-winning director Charles Mattocks to air Eight Days, ... first reality TV series of its kind, Eight Days first aired on the ...
(Date:8/5/2020)... ... August 04, 2020 , ... Alpine ... and has continued to refine their medical device assessment and penetration testing ... device manufacturing facilities to provide testing onsite, at client facilities. Due to ...
Breaking Medicine Technology:
Cached News: